Recently, our company has reached a strategic cooperation with Boya united pharmaceutical institute CO.,LTD. on the Toutongding Syrup (100ml/bottle), to obtain the exclusive agency of the product.
MoreOn September 17-19, 2020, the 83rd PHARM CHINA was held in Guangzhou. PHARM CHINA is a professional event of great scale and influence in the field of preparations and grand health in China. The exhibition covers an area of 100,000 square meters, wit
MoreRecently, we have received the Supplementary Drug Application Approval from the NMPA for Libeisi® - calcium dobesilate tablets (0.5g). The product has passed the generic drug consistency evaluation, indicating that it has reached the level of consist
MoreNanjing Changao Pharmaceutical Science and Technology Co., Limited responded to the epidemic in the first half of the year with efforts to prevent and control COVID-19 in Meiao park.
MoreWe have recently received the approval of the NMPA for the issuance of the Drug Registration Approval, and the marketing approval of pitavastatin calcium tablets (2 mg), a new generation of statins for lipid regulation, is regarded as passing the con
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page